General Information of the Compound
Compound ID |
CP0369808
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(3R)-N-[2-(4-cyanophenyl)ethyl]-1-[5-fluoro-4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]piperidine-3-carboxamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C25H32FN7O
|
||||||||||||||||||
Molecular Weight |
465.577
|
||||||||||||||||||
Canonical SMILES |
CN1CCN(CC1)c1nc(nc(C)c1F)N1CCC[C@H](C1)C(=O)NCCc1ccc(cc1)C#N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C25H32FN7O/c1-18-22(26)23(32-14-12-31(2)13-15-32)30-25(29-18)33-11-3-4-21(17-33)24(34)28-10-9-19-5-7-20(16-27)8-6-19/h5-8,21H,3-4,9-15,17H2,1-2H3,(H,28,34)/t21-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
MQTKTGBFRROXDQ-OAQYLSRUSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02509, G-protein coupled bile acid receptor 1
Protein ID: PT04975, G-protein coupled bile acid receptor 1